Cresco Labs Expands High Supply Brand Portfolio to Include 1.0 g and 0.5 mg Live Cartridges Available in California and Illinois
The Company is focused on growing its House of Brands to include trusted brands and quality products at different price points to deliver more choice and ongoing value to its markets, patients and customers
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated, multistate cannabis operators in the United States, announced today it has launched 1.0 g and 0.5 mg Live Cartridges from its High Supply line in dispensaries across California and Illinois. Cresco Labs has built a robust portfolio with eight distinct brands offering quality cannabis products at different price points to meet the diverse needs of its different markets, patients and customers. The new High Supply Live Cartridges complement the existing brand portfolio and deliver 100% cannabis oil rich in flavorful live terpenes with approachable pricing for cannabis enthusiasts and value shoppers alike.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210128005302/en/
Cresco Labs’ High Supply expanded portfolio includes 1.0 g and 0.5 mg Live Cartridges now available for purchase in California and Illinois. (Photo: Business Wire)
“We are continuing to work to round out our brand portfolio with a variety of price points and products targeted towards different users and occasions. Our focus on building our House of Brands has led to widespread success with strong growth from both our new brands like High Supply and our existing portfolio of brands,” said Greg Butler, Chief Commercial Officer at Cresco Labs. “We believe the focus we’ve put on the middle two verticals, brands and wholesale distribution, combined with a diversified branded portfolio approach will continue to drive sustainable long-term results.”
The launch of High Supply Live Cartridges follows the recent market introduction of the Company’s Cresco 1.0 g liquid live resin vape cartridges. High Supply Live Cartridges use quality cannabis flower that is carefully extracted to a broad-spectrum oil. The natural cannabis aromas and flavors are enhanced by blending in live resin terpenes extracted from fresh frozen material. The final products are one-of-a-kind cartridges that offer smooth, tasty and potent vapor experiences. High Supply Live Cartridges never contain THC boosters, distillate or other harmful additives like MCT oil and vitamin E acetate. They come in a variety of Sativa, Indica and Hybrid terpene blends and are competitively priced among other vapes in California and Illinois. Both Cresco and High Supply vape offerings allow the Company to offer a wide variety of popular products at price points appealing to various consumer segments in California and Illinois.
Over the last year, Cresco Labs has widened its breadth of branded product offerings in California and Illinois to include Cresco premium flower, pre-rolled joints, live resin concentrates and liquid live resin vape cartridges; Mindy’s Chef Led Artisanal Edibles gummies and chocolates; Remedi capsules, Rick Simpson (RSO) syringes and tinctures; High Supply flower, popcorn, shake, pre-rolled joints, vape pens and live vape cartridges; Good News pre-rolled shorties, gummies and vape pens; Wonder Wellness Co. Wonder Minis; and FloraCal Farms premium flower and pre-rolled joints.
High Supply is available in California, Illinois and Arizona. For more information, please visit HighSupplyOfficial.com .
About Cresco Labs
Cresco Labs is one of the largest vertically integrated, multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted brands including Cresco, Remedi, High Supply, Cresco Reserve, Good News, Wonder Wellness, FloraCal Farms and Mindy’s Chef Led Artisanal Edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at CrescoLabs.com .
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the company’s Annual Information Form dated April 28, 2020, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
Jason Erkes, Cresco Labs
Chief Communications Officer
Senior Analyst, Investor Relations
For general Cresco Labs inquiries:
News Provided by Business Wire via QuoteMedia
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or